7.01
Aquestive Therapeutics Inc Borsa (AQST) Ultime notizie
Is Aquestive Therapeutics Inc. stock ready for a breakoutPortfolio Risk Report & Intraday High Probability Alerts - newser.com
Real time alert setup for Aquestive Therapeutics Inc. performanceRate Hike & Entry Point Strategy Guides - newser.com
Can trapped investors hope for a rebound in Aquestive Therapeutics Inc.Market Growth Review & Low Drawdown Investment Ideas - newser.com
Top chart patterns to watch in Aquestive Therapeutics Inc.Quarterly Performance Summary & Daily Volume Surge Signals - newser.com
Why Aquestive Therapeutics Inc. stock could outperform in 2025July 2025 Sector Moves & High Win Rate Trade Tips - newser.com
Are Medical Stocks Lagging Aquestive Therapeutics (AQST) This Year? - sharewise.com
Is Aquestive Therapeutics Inc. stock attractive for retirement portfoliosJuly 2025 Catalysts & Fast Exit Strategy with Risk Control - newser.com
Volatility clustering patterns for Aquestive Therapeutics Inc.July 2025 Final Week & Real-Time Volume Spike Alerts - newser.com
Is Aquestive Therapeutics Inc. reversing from oversold territoryJuly 2025 Market Mood & Safe Entry Momentum Tips - newser.com
Aquestive Therapeutics Stock: A Measured Bet (NASDAQ:AQST) - Seeking Alpha
Aquestive Therapeutics (NASDAQ:AQST) Hits New 12-Month HighShould You Buy? - MarketBeat
Aquestive Therapeutics (NASDAQ:AQST) Advances Pharma Delivery - Kalkine Media
Aquestive Therapeutics (NASDAQ:AQST) Shares Up 7%Still a Buy? - MarketBeat
Aquestive Therapeutics (AQST) Surges 7.9%: Is This an Indication of Further Gains? - Yahoo Finance
Watching the Narrative for Aquestive Therapeutics Shift After Key Anaphylm Milestones - Yahoo Finance
How to build a dashboard for Aquestive Therapeutics Inc. stockStock Surge & Momentum Based Trading Signals - newser.com
Weiss Ratings Reiterates Sell (D-) Rating for Aquestive Therapeutics (NASDAQ:AQST) - MarketBeat
JMP Securities Maintains Aquestive Therapeutics (AQST) Market Outperform Recommendation - Nasdaq
What high frequency data says about Aquestive Therapeutics Inc.July 2025 Trends & Free Weekly Chart Analysis and Trade Guides - newser.com
Aquestive Therapeutics Broadens Patent Estate for Anaphylm™ - GlobeNewswire
Aquestive Therapeutics Shares Rise After Obtaining 2 New US Patents for Anaphylm Sublingual Film - MarketScreener
Aquestive Therapeutics Obtains 2 New US Patents for Anaphylm Sublingual Film - MarketScreener
Aquestive receives two new patents for oral anaphylaxis treatment By Investing.com - Investing.com Australia
Aquestive receives two new patents for oral anaphylaxis treatment - Investing.com India
Aquestive Therapeutics Broadens Patent Estate for Anaphylm™ - GlobeNewswire Inc.
Signal strength of Aquestive Therapeutics Inc. stock in tech scanners2025 Technical Patterns & Safe Capital Growth Trade Ideas - newser.com
Why Aquestive Therapeutics Inc. stock is seen as undervaluedWeekly Profit Summary & Community Verified Watchlist Alerts - newser.com
Custom watchlist performance reports with Aquestive Therapeutics Inc.2025 Dividend Review & Free Expert Verified Stock Movement Alerts - newser.com
Statistical indicators supporting Aquestive Therapeutics Inc.’s strengthTrade Analysis Summary & Comprehensive Market Scan Insights - newser.com
Advanced analytics toolkit walkthrough for Aquestive Therapeutics Inc.Portfolio Profit Report & AI Forecast for Swing Trade Picks - newser.com
Aquestive Therapeutics Advances Anaphylm Clinical Development - TipRanks
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):